27th National Clinical Education Symposium Presentation Abstracts

Actions for Presentation

Download PDF Back to list

Other presentations

Psychometric properties of the Turkish version of the Mild Behavioral Impairment Checklist in people with subjective cognitive decline - Page 75
İmge Coşkun Pektaş, İsmail Peker

The association of sleep quality with decision making and executive functı?ons in patients with panic disorder followed for three months - Page 76-77
Hediye Hilal Okucu, Deniz Alçı

Investigation of Depression, Social Anxiety Disorder, Functionality, and Quality of Life Levels in Patients with Pterygium: A Case-Control Study - Page 78
Şeyma Sehlikoğlu, Burak Ören

The Effect of Online Mindfulness-Based Stress Reduction on Mindfulness, Pain Severity, Functionality, and Somatosensory Temporal Discrimination Ability in Patients with Fibromyalgia Syndrome - Page 79
Sena Çağlayan, Selcuk Aslan, Merve Çöldür, Selim Yasin Boğa, Zafer Günendi

Determination of iron deficiency rates in male patients with depressive disorder: preliminary results - Page 80
Merve Şahin Can, Rıza Gökçer Tulacı, Çiğdem Kaçkan

Relationship Between Systemic Inflammatory Markers and Lithium Response in Bipolar 1 Disorder - Page 81
Olcay Şenay, Bahri İnce

29 APRIL 2025, TUESDAY
10:15-11:30 ORAL PRESENTATION SESSION - 5

Investigation of Somatization, Mental Capacity and Verbal Fluency in Alexithymic and Non-Alexithymic Patients Applying to Psychiatry Outpatient Clinic

Büşra Batur1, Nagehan Özkan Yaman1, Mehmet Ak1, Şakir Gıca1

1. Department of Psychiatry, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey

DOI: 10.5080/kes27.abs51 Page 74

BACKGROUND AND AIM:A review of the literature shows a significant relationship between alexithymia and somatization, with growing interest in recent years. Identifying mediating factors is key to understanding the underlying mechanism. This study compares somatization symptoms, mental capacity, and verbal fluency in patients with and without alexithymia, independent of diagnosis.
METHODS (Ethics Committee Approval must be obtained and the number should be specified.):Current study included 72 patients who consecutively applied to Necmettin Erbakan University Faculty of Medicine psychiatry outpatient clinic. Informed consent was obtained. Participants completed a sociodemographic form, Patient Health Questionnaire(PHQ-15), Beck Depression Inventory(BDI), Beck Anxiety Inventory(BAI), Verbal Fluency Test, National Adult Reading Test-Turkey(NART-TR), Toronto Alexithymia Scale(TAS-20). Research necessary permissions were obtained from the local ethics committee(IRB Date/Number:2025/5493).
RESULTS:A total of 72 patients were included: 31 with Anxiety Disorder, 20 with Major Depressive Disorder, 7 with Obsessive-Compulsive Disorder, 6 with Attention Deficit Hyperactivity Disorder, 4 with Bipolar Affective Disorder, and 4 with Psychotic Disorder. When evaluated based on the TAS-20 cutoff score, 27 were alexithymic. No significant differences were found between groups in gender, marital status, living arrangements, or employment(p=0.950, p=0.301, p=0.410, p=0.369, respectively). The mean age of the patient group with alexithymia and the presence of family history were found to be low(p=0.044, p=0.025, respectively). The alexithymic group had higher mean scores on the BAI, BDI, and PHQ-15(p=0.003, p=0.000, p=0.004, respectively). However, no statistically significant differences were found in the NART-TR and verbal fluency subscales(p=0.884, p>0.05). Nevertheless, a moderate positive correlation was observed between alexithymia and somatization scores(r=0.540), while no significant correlation was found between alexithymia with NART-TR and verbal fluency scores(r=-0.094, r=0.097, respectively).
CONCLUSIONS:The result of present study support the relationship between alexithymia and somatization, consistent with the literature. However, the relationship between alexithymia and verbal fluency or mental capacity was non-significant, contrary to our expectations. Further studies with larger and more homogeneously designed samples across patient groups are needed.